Search Videos by Topic or Participant
Browse by Series:

Cost and Quality Considerations in CINV Management

Insights From: Eric Roeland, MD, UC San Diego Health; James Natale, PharmD,BCOP, UPMC; Charles Loprinzi, MD, Mayo Clinic Rochester
Published: Thursday, Dec 17, 2015


Chemotherapy-induced nausea and vomiting (CINV) is a major reason for readmissions to the hospital post chemotherapy, according to James Natale, PharmD, BCOP. The use of standard protocols, along with electronic medical records, helps to reduce the rate of readmissions and improve outcomes.

There are various quality-related fee-for-performance guidelines being implemented that are related to the prevention of CINV, says Natale. The use of combination products that target multiple mechanisms in CINV prevention can offer an added convenience, he says, as well as help with oral chemotherapy medication adherence.

Any cost calculations associated with CINV management should take into consideration the efficacy of the antiemetic agent, explains Natale. The total cost of care for CINV increases if there is a lot of breakthrough nausea and vomiting, which may lead to the need for intravenous fluids and/or additional antiemetics. One of the best ways to reduce overall costs is to prevent CINV from ever occurring, adds Natale. Also, it is important to consider the patient cost. It is preferable to choose the most effective, as well as cost-effective agent.
Slider Left
Slider Right


Chemotherapy-induced nausea and vomiting (CINV) is a major reason for readmissions to the hospital post chemotherapy, according to James Natale, PharmD, BCOP. The use of standard protocols, along with electronic medical records, helps to reduce the rate of readmissions and improve outcomes.

There are various quality-related fee-for-performance guidelines being implemented that are related to the prevention of CINV, says Natale. The use of combination products that target multiple mechanisms in CINV prevention can offer an added convenience, he says, as well as help with oral chemotherapy medication adherence.

Any cost calculations associated with CINV management should take into consideration the efficacy of the antiemetic agent, explains Natale. The total cost of care for CINV increases if there is a lot of breakthrough nausea and vomiting, which may lead to the need for intravenous fluids and/or additional antiemetics. One of the best ways to reduce overall costs is to prevent CINV from ever occurring, adds Natale. Also, it is important to consider the patient cost. It is preferable to choose the most effective, as well as cost-effective agent.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x